Characterization of orphan human cytochromes P450

被引:47
作者
Stark, Katarina
Guengerich, F. Peter
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA
关键词
cytochrome P450; orphan enzymes; drug metabolism; bioactivation; carcinogenesis;
D O I
10.1080/03602530701467708
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Of the 57 human cytochromes P450 (P450) and 58 pseudogenes discovered to date, (http:// drinelson.utmem.edu/CytochromeP450.html), 1/4 still remain "orphans" in the sense that their function, expression sites, and regulation are still largely not elucidated. The posthuman genome-sequencing project era has presented the research community with novel challenges. Despite many insights gathered about gene location and genetic variations in our human genome, we still lack important knowledge about these novel P450 enzymes and their functions in endogenous and exogenous metabolism, as well as their possible roles in the metabolism of toxicants and carcinogens. Our own list of such orphans currently consists of 13 members: P450 2A7, 2S1, 2U1, 2W1, 3A43, 4A22, 4F11, 4F22, 4V2, 4X1, 4Z1, 20A1, and 27C1. Some of the orphans, e.g. P450s 2W1 and 2U1, already have putative assigned functions in arachidonic acid metabolism and may activate carcinogens. However, at this point, for the majority of them more knowledge is available about their genes and single nucleotide polymorphisms than of their biological functions. It is noteworthy that most P450 orphans express high interspecies sequence conservation and have orthologs in rodents (e.g. CYP4X1/Cyp4x1, CYP4V2/Cyp4v3). This review summarizes recent knowledge about the P450 orphans and questions remaining about their specific roles in human metabolism.
引用
收藏
页码:627 / 637
页数:11
相关论文
共 53 条
[41]   Identification and tissue distribution of the novel human cytochrome P4502S1 (CYP2S1) [J].
Rylander, T ;
Neve, EPA ;
Ingelman-Sundberg, M ;
Oscarson, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (02) :529-535
[42]  
Saarikoski Sirkku T, 2005, Toxicol Appl Pharmacol, V207, P62, DOI 10.1016/j.taap.2004.12.027
[43]   Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population [J].
Saarikoski, ST ;
Suitiala, T ;
Holmila, R ;
Impivaara, O ;
Järvisalo, J ;
Hirvonen, A ;
Husgafvel-Pursiainen, K .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 554 (1-2) :267-277
[44]   Untargeted analysis of mass spectrometry data for elucidation of metabolites and function of enzymes [J].
Sanchez-Ponce, Raymundo ;
Guengerich, F. Peter .
ANALYTICAL CHEMISTRY, 2007, 79 (09) :3355-3362
[45]   Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2 [J].
Sansen, Stefaan ;
Yano, Jason K. ;
Reynald, Rosamund L. ;
Schoch, Guillaume A. ;
Griffin, Keith J. ;
Stout, C. David ;
Johnson, Eric F. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (19) :14348-14355
[46]   Conditional regulation of the human CYP4X1 and CYP4Z1 genes [J].
Savas, O ;
Hsu, MH ;
Griffin, KJ ;
Bell, DR ;
Johnson, EF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 436 (02) :377-385
[47]   Cutaneous expression of cytochrome P450CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases [J].
Smith, G ;
Wolf, CR ;
Deeni, YY ;
Dawe, RS ;
Evans, AT ;
Comrie, MM ;
Ferguson, J ;
Ibbotson, SH .
LANCET, 2003, 361 (9366) :1336-1343
[48]  
Stark K, 2004, BASIC CLIN PHARMACOL, V94, P177
[49]   Screening for mutations in CYP4V2 gene in Japanese patients with Bietti's crystalline corneoretinal dystrophy [J].
Wada, Y ;
Itabashi, T ;
Sato, H ;
Kawamura, M ;
Tada, A ;
Tamai, M .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (05) :894-899
[50]   Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43 [J].
Westlind, A ;
Malmebo, S ;
Johansson, I ;
Otter, C ;
Andersson, TB ;
Ingelman-Sundberg, M ;
Oscarson, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (05) :1349-1355